US FDA and EMA to pilot parallel quality assessments
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration and the European Medicines Agency are teaming up under a new pilot programme to jointly evaluate drug development and manufacturing data created using the quality-by-design approach1,2.